Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,379.00    -22.50 (-0.51%)
Bid:
4,378.50
Ask:
4,379.00
Spread: 0.50 (0.011%)
Market Cap: £94.82b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Board changes

18 Feb 2021 13:00

RNS Number : 6100P
Unilever PLC
18 February 2021
 

Unilever PLC - Board Changes

 

 

London, 18 February 2021. Unilever announced today that, following his appointment as Italy's Minister for Technological Innovation and Digital Transition, Vittorio Colao has asked to step down from the Board.

 

Nils Andersen, Chairman of Unilever, said: "Vittorio has brought a high degree of knowledge and insight to us in over five years on our Board and has skilfully chaired our Compensation Committee. He will be greatly missed and we wish him the best of success in his new role serving the Italian Cabinet."

 

Following this change, effective today, Andrea Jung will serve as Chair of Unilever's Compensation Committee.

 

 

 

Media: Media Relations team

 

+44 78 2527 3767

lucila.zambrano@unilever.com

Investors: Investor Relations team

 

+44 20 7822 6830

investor.relations@unilever.com

 

 

 

SAFE HARBOUR

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group" or "Unilever"). They are not historical facts, nor are they guarantees of future performance. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current COVID-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission (the "SEC"), including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALVLFFFLLFBBL
Date   Source Headline
3rd Nov 202512:20 pmRNSTotal Voting Rights
30th Oct 20251:34 pmRNSPublication of Final Terms
30th Oct 202512:00 pmRNSStatement re AGM Vote
28th Oct 20254:00 pmRNSDirector/PDMR Shareholding
27th Oct 20255:16 pmRNSDirector/PDMR Shareholding
24th Oct 20254:19 pmRNSPublication Supplement
23rd Oct 20257:00 amRNSQ3 2025 Trading Statement
21st Oct 202510:20 amRNSResult of General Meeting
21st Oct 20257:00 amRNSStatement regarding Demerger & Share Consolidation
7th Oct 202510:42 amRNSAppointment of NED
2nd Oct 20257:00 amRNSShareholder Circular, Notice of General Meeting
1st Oct 20254:35 pmRNSTotal Voting Rights
22nd Sep 20257:00 amRNSDirector/PDMR Shareholding - Amendment
19th Sep 20251:18 pmRNSDirector/PDMR Shareholding
17th Sep 20253:41 pmRNSDirector/PDMR Shareholding
17th Sep 20259:40 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSDirectorate Change
15th Sep 202511:57 amRNSBlock listing Interim Review
3rd Sep 20256:07 pmRNSPublication of Final Terms
1st Sep 20254:13 pmRNSTotal Voting Rights
1st Aug 20252:33 pmRNSTotal Voting Rights
31st Jul 20253:03 pmRNSPublication of Supplement
31st Jul 20257:00 amRNS2025 First Half Results
1st Jul 202512:55 pmRNSTotal Voting Rights
1st Jul 20259:35 amRNSDirector/PDMR Shareholding
20th Jun 20253:25 pmRNSDirector/PDMR Shareholding
18th Jun 20252:28 pmRNSDirector/PDMR Shareholding
17th Jun 20254:06 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:18 pmRNSTotal Voting Rights
30th May 20256:29 pmRNSCompletion of Share Buyback
30th May 20256:28 pmRNSTransaction in Own Shares
30th May 20255:36 pmRNSPUBLICATION OF UFN FINANCIAL STATEMENTS
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20259:22 amRNSPublication of Final Terms: Unilever Bonds
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20252:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.